MicroSynbiotiX

Microalgae synthetic biology company for oral delivery of vaccines to animals

Based based in Ireland, MicroSynbiotiX works in agtech, founded in 2016.

Profile

MicroSynbiotiX is developing cost-effective oral vaccines to combat infections and improve global food security. We are developing a novel method of producing oral vaccines using transgenic microalgae. Our solution will make disease management much more sustainable and reduce the need for antibiotics.

Within the agtech space, the company focuses on its core offering rather than a broad product line.

The business is associated with Ireland.

Its current recorded stage is SOSV portfolio company.

Its team size is recorded as 2-10 employees.

Total disclosed funding stands at about $1.5M.

Website: microsynbiotix.com